We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Heiq Plc | LSE:HEIQ | London | Ordinary Share | GB00BN2CJ299 | ORD GBP0.05 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.23 | 2.54% | 9.28 | 9.10 | 9.46 | 9.10 | 8.82 | 8.82 | 171,213 | 16:35:12 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 48.1M | -29.25M | -0.2081 | -0.44 | 12.79M |
Date | Subject | Author | Discuss |
---|---|---|---|
28/6/2023 20:33 | Could they have had any banking relationship with Credit Suisse? | pugugly | |
28/6/2023 19:56 | Agreed! They’re taking the biscuit! | catabrit | |
28/6/2023 17:34 | how long is temporary? it's been almost 2 months! | davemac3 | |
23/6/2023 14:48 | Reading the RNS once again, it says: "Given that the Company's financial reporting processes and the associated audit for the 12 months ended 31 December 2022 are still in progress, the Company intends to invite shareholders to another meeting to vote on the approval of the Annual Report and related matters as soon as these processes are completed, and the Annual Report is duly published. The Company will provide an update on its Annual Results 2022 and publication of Annual Report 2022 as soon as it is in a position to do so...." This means, the AGM is just a formal thing, with no news on the results of 2022. Is this correct? | unluckyluke | |
16/6/2023 20:50 | Management may be very clever chemists but (imo) would not appear from their progress to date to pass Marketing and sales 101. Edited 23/6/23 Also appear to have failed book-keeping and accountancy at A level | pugugly | |
16/6/2023 20:36 | Take private at 10p would not surprise me. Lost credibility with me . Fd should go at the least | edwardt | |
16/6/2023 11:02 | I suspect they’re taking advantage of the suspension to undertake some sort of strategic review considering the disconnect between the share price and management’s view of intrinsic value. It wouldn’t surprise me if something is announced post resumption of trading. | catabrit | |
06/6/2023 07:31 | On May 2nd they said they thought they'd be able to publish the accounts " in the coming weeks" - and in the prev one that this had been "as a result of the acquisition and implementation of new systems as well as changes to processes within the organisation". The reasoning is a bit vague - but I guess we're still in the "coming weeks" so hopefully no cause for alarm. Is this kind of delay more common in Switzerland? I've no idea. | value hound | |
06/6/2023 07:23 | rns out - Reading between the lines as still have not been able to finalise accounts potentially major problems uncovered - Just my opinion from the wording - may well have misinterpreted - Other views?? "Given that the Company's financial reporting processes and the associated audit for the 12 months ended 31 December 2022 are still in progress, the Company intends to invite shareholders to another meeting to vote on the approval of the Annual Report and related matters as soon as these processes are completed, and the Annual Report is duly published. The Company will provide an update on its Annual Results 2022 and publication of Annual Report 2022 as soon as it is in a position to do so. An in-depth update on strategy and 2023 trading will be provided together with the publication of the Annual Report 2022." | pugugly | |
24/5/2023 17:16 | I asked IR that recently as a follow-up and never got a response. I’ll ask again. | catabrit | |
24/5/2023 08:37 | Thanks for that. Hi all, any news on HeiQ? Has anybody heard of a specific date, when the results will be published? | unluckyluke | |
16/5/2023 10:51 | FWIW - Polygiene AB (ticker: POLYG.ST) is not a bad comp for HEIQ. If you apply the same market cap to sales (a metric that’s now redundant, admittedly) you get a share price that’s 30-40% higher. And obviously that excludes AeoniQ and the claim against ICP. HEIQ’s IR function is pretty poor but they have claimed they will reduce headcount / costs before they consider doing an equity raise. Now take that with a pinch of salt as I’m sure many companies say the same thing but let’s not forget that management and prior longstanding shareholders still own ~25% of the stock. I think it’s hard to attribute a probability to what the upside might be here but the more I dig into this, the safer I feel with my basis at 18p odd. For those with a higher in-price, it might take a while to recover your losses but there’s definitely a lot of potential here and I feel this is more of a fallen angel than a dud but I could be wrong. I’ll continue to share what I find. I plan to do more detailed scuttlebutt with industry insiders over the coming weeks. | catabrit | |
12/5/2023 22:37 | Someone seems to down tick every post. I wouldn’t lose sleep over it. | dr biotech | |
12/5/2023 20:30 | Whoever downvoted what I thought would be useful information, care to explain? | catabrit | |
12/5/2023 15:02 | Anyone that is long HEIQ should check out the Renewcell Capital Markets Day which was held this week. They have a monopoly in cellulose it seems and the filament yarn that AeoniQ makes uses their feed. They have a market cap of 3.5bn SEK or circa £280m. I can see why Carlo and the team are bullish on AeoniQ’s prospects. Whether it’s regulatory, customer (brands) or consumer they’re skating to where the puck is going. | catabrit | |
30/4/2023 11:49 | Dr Biotech, My understanding of the 'one year guideline' is that you 'restart the clock' with each subsequent profit warning. Profit warnings sometimes come in sequences, so an advantage of waiting a year is that it gives more time to see whether that's likely to happen or not. You also of course have to apply your own judgement, considering all relevant factors. HEIQ has never been prompt in its warnings, so that's a relevant factor to allow for. It's wise to thoroughly examine RNSes for indications of potential profit warnings to come. For example, this snippet about 'energy prices challenges' etc. is the sort of thing that can be a 'veiled warning':- 02/12/2022 07:00 UK Regulatory (RNS & others) HeiQ PLC Acquisition of Chem-Tex Laboratories, Inc LSE:HEIQ Heiq Plc " ... This Acquisition is expected to improve HeiQ's operating margin in 2023 and beyond and will also enable HeiQ to focus its future manufacturing investments in the USA, which have proven to be less exposed to energy price increases and critical base chemical raw materials availability challenges experienced in Europe in the recent years. ..." | hedgehog 100 | |
29/4/2023 19:49 | Heiq also warned at a similar time at 140p… | dr biotech | |
29/4/2023 14:30 | This has certainly been one to forget about for holders so far! But of course if the company's results recover, then the share price should do likewise. Anyone considering a HEIQ buy after the return from suspension may be interested in this research:- "What to do when one of your stocks warns on profit We discuss how share prices react in the aftermath of a profit alert 06 June 2019|Feature ... RECOVERY FROM A WARNING DEPENDS ON CIRCUMSTANCES A study by UK finance professors George Bulkley, Richard Harris and Renata Herrerias looked at 455 profit warnings issued between 1997 and 1999 and tracked the stocks until 2001. Unlike some of the other studies that we discussed, this study looked further ahead. It tracked future earnings announcements that were released to the market. It found that between 12 and 24 months after a profit warning, the average cumulated excess daily returns of these stocks was a positive 23% relative to the market. In other words, the stocks showed strong signs of recovery between one and two years after the warning. This can be explained by analysts being slow to change their opinions, even in the face of new information. ..." The period of a year gives sufficient time for the share price to deflate, and for business recovery to take place and be sufficiently reported. And it's also partly psychological: the one year period gives sufficient time for 'emotional healing'; and there's an element of 'self-fulfilling prophecy' re standard expectations of the common time period before recovery. A good recent example of this 'one year rule' working well is NWT (Newmark Security). After its 15th. October 2021 trading update the company's share price nearly halved over the following twelve months. But since its 27th. October 2022 trading update, its share price has more than doubled (from 25.5p to 56.5p), on improved trading. "Newmark Security in 2023: A Transformed Tech & USA Success Story" Newmark Security (NWT):- | hedgehog 100 | |
28/4/2023 19:54 | Yes - quite possibly a several-bagger from here. One to buy and forget about; anything is possible from this point. | value hound | |
28/4/2023 16:11 | Lots of risk here but we're at a big discount to the implied $200m valuation of AEONI. You also have a $100m claim against ICP. So we're paying 15c in the $ for both and get the rest of the business lines for free. If they get anywhere close to their medium term revenue target (300m GBP I think) we're looking at amazing upside considering that their gross margins are circa 50%. | catabrit | |
28/4/2023 12:27 | I also bought some today. Seems a ridiculous price | boystown |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions